Comparison of diagnostic accuracy of rapid antigen tests for COVID19 compared to the viral genetic test in adults: a systematic review and meta-analysis.
Journal
JBI evidence synthesis
ISSN: 2689-8381
Titre abrégé: JBI Evid Synth
Pays: United States
ID NLM: 101764819
Informations de publication
Date de publication:
26 Aug 2024
26 Aug 2024
Historique:
medline:
27
8
2024
pubmed:
27
8
2024
entrez:
27
8
2024
Statut:
aheadofprint
Résumé
The objective of this review is to determine the diagnostic accuracy of the currently available and upcoming point-of-care rapid antigen tests (RATs) used in primary care settings relative to the viral genetic real-time reverse transcriptase polymerase chain reaction (RT-PCR) test as a reference for diagnosing COVID-19/SARS-CoV-2 in adults. Accurate COVID-19 point-of-care diagnostic tests are required for real-time identification of SARS-CoV-2 infection in individuals. Real-time RT-PCR is the accepted gold standard for diagnostic testing, requiring technical expertise and expensive equipment that are unavailable in most primary care locations. RATs are immunoassays that detect the presence of a specific viral protein, which implies a current infection with SARS-CoV-2. RATs are qualitative or semi-quantitative diagnostics that lack thresholds that provide a result within a short time frame, typically within the hour following sample collection. In this systematic review, we synthesized the current evidence regarding the accuracy of RATs for detecting SARS-CoV-2 compared with RT-PCR. Studies that included nonpregnant adults (18 years or older) with suspected SARS-CoV-2 infection, regardless of symptomology or disease severity, were included. The index test was any available SARS-CoV-2 point-of-care RAT. The reference test was any commercially distributed RT-PCR-based test that detects the RNA genome of SARS-CoV-2 and has been validated by an independent third party. Custom or in-house RT-PCR tests were also considered, with appropriate validation documentation. The diagnosis of interest was COVID-19 disease and SARS-CoV-2 infection. This review considered cross-sectional and cohort studies that examined the diagnostic accuracy of COVID-19/SARS-CoV-2 infection where the participants had both index and reference tests performed. The keywords and index terms contained in relevant articles were used to develop a full search strategy for PubMed and adapted for Embase, Scopus, Qinsight, and the WHO COVID-19 databases . Studies published from November 2019 to July 12, 2022, were included, as SARS-CoV-2 emerged in late 2019 and is the cause of a continuing pandemic. Studies that met the inclusion criteria were critically appraised using QUADAS-2. Using a customized tool, data were extracted from included studies and were verified prior to analysis. The pooled sensitivity, specificity, positive predictive, and negative predictive values were calculated and presented with 95% CIs. When heterogeneity was observed, outlier analysis was conducted, and the results were generated by removing outliers. Meta-analysis was performed on 91 studies of 581 full-text articles retrieved that provided true-positive, true-negative, false-positive, and false-negative values. RATs can identify individuals who have COVID-19 with high reliability (positive predictive value 97.7%; negative predictive value 95.2%) when considering overall performance. However, the lower level of sensitivity (67.1%) suggests that negative test results likely need to be retested through an additional method. Most reported RAT brands had only a few studies comparing their performance with RT-PCR. Overall, a positive RAT result is an excellent predictor of a positive diagnosis of COVID-19. We recommend that Roche's SARS-CoV-2 Rapid Antigen Test and Abbott's BinaxNOW tests be used in primary care settings, with the understanding that negative results need to be confirmed through RT-PCR. We recommend adherence to the STARD guidelines when reporting on diagnostic data. PROSPERO CRD42020224250.
Identifiants
pubmed: 39188132
doi: 10.11124/JBIES-23-00291
pii: 02174543-990000000-00341
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc.
Déclaration de conflit d'intérêts
The authors declare no conflicts of interest.
Références
World Health Organization. WHO coronavirus (COVID-19) dashboard [internet]. World Health Organization; 2023 [cited 2023 Nov 8]. Available from: https://covid19.who.int/.
Saleh FA, Sleem A. COVID-19: test, test and test. Med Sci 2021;9(1):1.
Madhusoodanan J. Animal reservoirs—where the next SARS-CoV-2 variant could arise. JAMA 2022;328(8):696–698.
Borillo GA, Kagan RM, Marlowe EM. Rapid and accurate identification of SARS-CoV-2 variants using real time PCR assays. Front Cell Infect Microbiol 2022;12:894613.
Puhach O, Meyer B, Eckerle I. SARS-CoV-2 viral load and shedding kinetics. Nat Rev Microbiol 2023;21(3):147–161.
Venter M, Richter K. Towards effective diagnostic assays for COVID-19: a review. J Clin Pathol 2020;73(7):370–377.
Bwogi J, Lutalo T, Tushabe P, Bukenya H, Eliku JP, Ssewanyana I, et al. Field evaluation of the performance of seven antigen rapid diagnostic tests for the diagnosis of SARs-CoV-2 virus infection in Uganda. PLoS One 2022;17(5):e0265334.
Cattelan AM, Sasset L, Zabeo F, Ferrari A, Rossi L, Mazzitelli M, et al. Rapid antigen test LumiraDx™ vs. real time polymerase chain reaction for the diagnosis of SARS-CoV-2 infection: a retrospective cohort study. Int J Environ Res Public Health 2022;19(7):3826.
Safiabadi Tali SH, LeBlanc JJ, Sadiq Z, Oyewunmi OD, Camargo C, Nikpour B, et al. Tools and techniques for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)/COVID-19 detection. Clin Bicrobiol Rev 2021;34(3):e00228–20.
Liu M, Lyu J, Zheng X, Liang Z, Lei B, Chen H, et al. Evolution of the newest diagnostic methods for COVID-19: a Chinese perspective. J Zhejiang Univ Sci B 2023;24(6):463–484.
Freire ML, Alves LL, de Souza CS, Saliba JW, Faria V, Pedras MJ, et al. Performance differences among commercially available antigen rapid tests for COVID-19 in Brazil. PLoS One 2022;17(6):e0269997.
Scheiblauer H, Filomena A, Nitsche A, Puyskens A, Corman VM, Drosten C, et al. Comparative sensitivity evaluation for 122 CE-marked rapid diagnostic tests for SARS-CoV-2 antigen, Germany, September 2020 to April 2021. Euro Surveill 2021;26(44):2100441.
Bayona HH, Cabaluna IT, Dans L, Dans A. Diagnostic accuracy of rapid antigen tests for COVID-19. PROSPERO 2020. CRD42020205693.
Dinnes J, Deeks JJ, Berhane S, Taylor M, Adriano A, Davenport C, et al. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection. Cochrane Database Syst Rev 2021;3(3):CD013705.
Stegeman I, Ochodo EA, Guleid F, Holtman GA, Yang B, Davenport C, et al. Routine laboratory testing to determine if a patient has COVID-19. Cochrane Database Syst Rev 2020;11(11):CD013787.
Dinnes J, Sharma P, Berhane S, van Wyk SS, Nyaaba N, Domen J, et al. Rapid, point‐of‐care antigen tests for diagnosis of SARS‐CoV‐2 infection. Cochrane Database Syst Rev 2022;7(7):CD013705.
Campbell JM, Kulgar M, Ding S, Carmody DP, Hakonsen SJ, Jadotte YT, et al. Chapter 9: Diagnostic test accuracy systematic reviews. In: Aromataris E, Munn Z, editor. JBI Manual for Evidence Synthesis [internet]. JBI; 2020 [cited 2023 Nov 8]. Available from: https://synthesismanual.jbi.global
DeArmond M, Feliciano S, Hirabayashi E, Duus KM, Else TA, Stone AEL. Diagnostic accuracy of rapid antigen tests for COVID-19 compared to the viral genetic test in adults: a systematic review protocol. JBI Evid Synth 2021;19(5):1148–1156.
Verma N, Patel D, Pandya A. Emerging diagnostic tools for detection of COVID-19 and perspective. Biomed Microdevices 2020;22(4):83.
Shirato K, Tomita Y, Katoh H, Yamada S, Fukushi S, Matsuyama S, et al. Performance evaluation of real-time RT-PCR assays for the detection of severe acute respiratory syndrome coronavirus-2 developed by the National Institute of Infectious Diseases, Japan. Jpn J Infect Dis 2021;74(5):465–472.
Canadian Agency for Drugs and Technologies in Health. CADTH COVID-19 search strings [internet]. CADTH; 2020 [cited 2020 Oct 5]. Available from: https://covid.cadth.ca/literaturesearching-tools/cadth-covid-19-search-strings/.
McGowan J, Sampson M, Salzwedel DM, Cogo E, Foerster V, Lefebvre C. PRESS Peer Review of Electronic Search Strategies: 2015 Guideline Statement. J Clin Epidemiol 2016;75:40–46.
Bramer WM, Giustini D, de Jonge GB, Holland L, Bekhuis T. De-duplication of database search results for systematic reviews in EndNote. J Med Libr Assoc 2016;104(3):240–243.
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021;372:n71.
Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 2011;155(8):529–536.
Hodcroft EB. CoVariants: SARS-CoV-2 mutations and variants of interest [internet]. CoVariants; 2021 [cited 2023 Nov 8]. Available from: https://covariants.org/.
Balduzzi S, Rucker G, Schwarzer G. How to perform a meta-analysis with R: a practical tutorial. Evid Based Ment Health 2019;22(4):153–160.
Harrer M, Cuijpers P, Furukawa T, Ebert DD dmetar: companion R package for the guide ‘Doing Meta-Analysis in R’ [internet]. R package version 0.1.0.; 2019 [cited 2023 Nov 8]. Available from: http://dmetar.protectlab.org/.
McMaster University, Evidence Prime Inc. GRADEpro GDT: GRADEpro Guideline Development Tool. 2022.
Schünemann H, Brożüek J, Guyatt, Oxman A. GRADE handbook for grading quality of evidence and strength of recommendations. The GRADE Working Group; 2013. [cited 2023 Nov 8. Available from: https://gdt.gradepro.org/app/handbook/handbook.html.
Abdelrazik AM, Elshafie SM, Abdelaziz HM. Potential use of antigen-based rapid test for SARS-CoV-2 in respiratory specimens in low-resource settings in Egypt for symptomatic patients and high-risk contacts. Lab Med 2021;52(2):e46–e49.
Abusrewil Z, Alhudiri IM, Kaal HH, El Meshri SE, Ebrahim FO, Dalyoum T, et al. Time scale performance of rapid antigen testing for SARS-CoV-2: evaluation of 10 rapid antigen assays. J Med Virol 2021;93(12):6512–6518.
Afzal RK, Ali S, Ahmad F, Nasir S, Younas M, Ahmad T. Diagnostic accuracy of PANBIO COVID-19 rapid antigen method for screening in emergency cases. Pak Armed Forces Med J 2021;71(5):1607–1610.
Akashi Y, Horie M, Takeuchi Y, Togashi K, Adachi Y, Ueda A, et al. A prospective clinical evaluation of the diagnostic accuracy of the SARS-CoV-2 rapid antigen test using anterior nasal samples. J Infect Chemother 2022;28(6):780–785.
Al-Alawi S, Al-Hinai H, Al-Kindi N, Al-Rashidi M, Al-Kindi H, Al-Shukri I, et al. Evaluation of four rapid antigen tests for detection of SARS-CoV-2 virus. Oman Med J 2021;36(5):e297.
Aleem S, Zahoor N, Jeelani A, SalimKhan SM. Diagnostic accuracy of STANDARD QCOVID-19 antigen detection kit in comparison with RT-PCR assay using nasopharyngeal samples in India. J Clin Diagn Res 2022;16(1):DC01–DC05.
Alghounaim M, Bastaki H, Bin Essa F, Motlagh H, Al-Sabah S. The performance of two rapid antigen tests during population-level screening for SARS-CoV-2 infection. Front Med 2021;8:797109.
Allan-Blitz LT, Klausner JD. A real-world comparison of SARS-CoV-2 Rapid Antigen Testing versus PCR testing in Florida. J Clin Microbiol 2021;59(10):e0110721.
Amer RM, Samir M, Gaber OA, El-Deeb NA, Abdelmoaty AA, Ahmed AA, et al. Diagnostic performance of rapid antigen test for COVID-19 and the effect of viral load, sampling time, subject’s clinical and laboratory parameters on test accuracy. J Infect Public Health 2021;14(10):1446–1453.
Anastasiou OE, Holtkamp C, Schäfer M, Schön F, Eis-Hübinger AM, Krumbholz A. Fast detection of SARS-CoV-2 RNA directly from respiratory samples using a loop-mediated isothermal amplification (LAMP) test. Viruses 2021;13(5):801.
Avgoulea K, Beredaki MI, Vourli S, Siopi M, Siafakas N, Pournaras S. field evaluation of the new rapid NG-Test® SARS-CoV-2 Ag for diagnosis of COVID-19 in the emergency department of an academic referral hospital. Front Public Health 2022;10:840984.
Babu GR, Sundaresan R, Athreya S, Akhtar J, Pandey PK, Maroor PS, et al. The burden of active infection and anti-SARS-CoV-2 IgG antibodies in the general population: results from a statewide sentinel-based population survey in Karnataka, India. Int J Infect Dis 2021;108:27–36.
Bachman CM, Grant BD, Anderson CE, Alonzo LF, Garing S, Byrnes SA, et al. Clinical validation of an open-access SARS-COV-2 antigen detection lateral flow assay, compared to commercially available assays. PLoS One 2021;16(8):e0256352–e0256352.
Basso D, Aita A, Padoan A, Cosma C, Navaglia F, Moz S, et al. Salivary SARS-CoV-2 antigen rapid detection: a prospective cohort study. Clin Chim Acta 2021;517:54–59.
Blairon L, Wilmet A, Beukinga I, Tré-Hardy M. Implementation of rapid SARS-CoV-2 antigenic testing in a laboratory without access to molecular methods: Experiences of a general hospital. J Clin Virol 2020;129:104472.
Bond KA, Smith B, Gardiner E, Liew KC, Williams E, Walsham N, et al. Utility of SARS-CoV-2 rapid antigen testing for patient triage in the emergency department: a clinical implementation study in Melbourne, Australia. Lancet Reg Health West Pac 2022;25:100486.
Borro M, Salerno G, Montori A, Petrucca A, Anibaldi P, Marcolongo A, et al. SARS-CoV-2 transmission control measures in the emergency department: the role of rapid antigenic testing in asymptomatic subjects. Healthcare 2022;10(5):790.
Boum Y, Fai KN, Nicolay B, Mboringong AB, Bebell LM, Ndifon M, et al. Performance and operational feasibility of antigen and antibody rapid diagnostic tests for COVID-19 in symptomatic and asymptomatic patients in Cameroon: a clinical, prospective, diagnostic accuracy study. The Lancet Infect Dis 2021;21(8):1089–1096.
Bulilete O, Lorente P, Leiva A, Carandell E, Oliver A, Rojo E, et al. Panbio™ rapid antigen test for SARS-CoV-2 has acceptable accuracy in symptomatic patients in primary health care. J Infect 2021;82(3):391–398.
Burdino E, Cerutti F, Panero F, Allice T, Gregori G, Milia MG, et al. SARS-CoV-2 microfluidic antigen point-of-care testing in emergency room patients during COVID-19 pandemic. J Virol Methods 2022;299:114337.
Caruana G, Croxatto A, Kampouri E, Kritikos A, Opota O, Foerster M, et al. Implementing SARS-CoV-2 rapid antigen testing in the emergency ward of a Swiss university hospital: the INCREASE Study. Microorganisms 2021;9(4):798.
Caruana G, Lebrun LL, Aebischer O, Opota O, Urbano L, de Rham M, et al. The dark side of SARS-CoV-2 rapid antigen testing: screening asymptomatic patients. New Microbes New Infect 2021;42:100899.
Cassuto NG, Gravier A, Colin M, Theillay A, Pires-Roteira D, Pallay S, et al. Evaluation of a SARS-CoV-2 antigen-detecting rapid diagnostic test as a self-test: diagnostic performance and usability. J Med Virol 2021;93(12):6686–6692.
Cento V, Renica S, Matarazzo E, Antonello M, Colagrossi L, Di Ruscio F, et al. Frontline screening for SARS-CoV-2 infection at emergency department admission by third generation rapid antigen test: can we spare RT-qPCR? Viruses 2021;13(5):818.
Cerutti F, Burdino E, Milia MG, Allice T, Gregori G, Bruzzone B, et al. Urgent need of rapid tests for SARS CoV-2 antigen detection: evaluation of the SD-Biosensor antigen test for SARS-CoV-2. J Clin Virol 2020;132:104654.
Chaimayo C, Kaewnaphan B, Tanlieng N, Athipanyasilp N, Sirijatuphat R, Chayakulkeeree M, et al. Rapid SARS-CoV-2 antigen detection assay in comparison with real-time RT-PCR assay for laboratory diagnosis of COVID-19 in Thailand. Virol J 2020;17(1):177.
Cheng CC, Liu CC, Chiu TF, Shiou-Sheng Chen S. Evaluation of a rapid antigen test for the diagnosis of SARS-CoV-2 during the COVID-19 pandemic. Inquiry 2022;59:469580221105354.
Choudhary SIA. Validation of rapid SARS-COV-2 antigen detection test as a screening tool for detection of Covid-19 infection at district hospital in northern India. Asian J Med Sci 2022;13(4):7–10.
Cottone E, Van Hoecke F, Martens GA, De Laere E, De Smedt R, Vervaeke S, et al. Pitfalls of SARS-CoV-2 antigen testing at emergency department. Infect Dis (Lond) 2022;54(10):731–737.
Cubas-Atienzar AI, Bell F, Byrne RL, Buist K, Clark DJ, Cocozza M, et al. Accuracy of the Mologic COVID-19 rapid antigen test: a prospective multi-centre analytical and clinical evaluation [version 1; peer review 1: 1 approved with reservations]. Wellcome Open Res 2021;6:132.
Dierks S, Bader O, Schwanbeck J, Groß U, Weig MS, Mese K, et al. Diagnosing SARS-CoV-2 with antigen testing, transcription-mediated amplification and real-time PCR. J Clin Med 2021;10(11):2404.
Escribano P, Sánchez-Pulido AE, González-Leiva J, Valero-López I, Catalán P, Muñoz P, et al. Different performance of three point-of-care SARS-CoV-2 antigen detection devices in symptomatic patients and close asymptomatic contacts: a real-life study. Clin Microbiol Infect 2022;28(6):865–870.
Escrivá BF, Mochón MDO, González RM, García CS, Pla AT, Ricart AS, et al. The effectiveness of rapid antigen test-based for SARS-CoV-2 detection in nursing homes in Valencia, Spain. J Clin Virol 2021;143:1104941.
Faíco-Filho KS, Júnior FEF, Moreira LVL, Lins PRG, Justo AFO, Bellei N. Evaluation of the Panbio™ COVID-19 ag rapid test at an emergency room in a hospital in São Paulo, Brazil. Braz J Infect Dis 2022;26(2):102349.
Farfour E, Amiel C, Jolly E, Zia-Chahabi S, Mazaux L, Simonin P, et al. The Panbio COVID-19 Ag Rapid Test: which performances are for COVID-19 diagnosis? Clin Lab 2021;67(11):2525–2532.
Fernandez-Montero A, Argemi J, Rodríguez JA, Ariño AH, Moreno-Galarraga L. Validation of a rapid antigen test as a screening tool for SARS-CoV-2 infection in asymptomatic populations. Sensitivity, specificity and predictive values. EClinicalMedicine 2021;37:100954.
Ferté T, Ramel V, Cazanave C, Lafon ME, Bébéar C, Malvy D, et al. Accuracy of COVID-19 rapid antigenic tests compared to RT-PCR in a student population: the StudyCov study. J Clin Virol 2021;141:104878.
Fitoussi F, Tonen-Wolyec S, Awaida N, Dupont R, Bélec L. Analytical performance of the point-of-care BIOSYNEX COVID-19 Ag BSS for the detection of SARS-CoV-2 nucleocapsid protein in nasopharyngeal swabs: a prospective field evaluation during the COVID-19 third wave in France. Infection 2021. [epub ahead of print].
Ford L, Whaley MJ, Shah MM, Salvatore PP, Segaloff HE, Delaney A, et al. Antigen test performance among children and adults at a SARS-CoV-2 community testing site. J Pediatric Infect Dis Soc 2021;10(12):1052–1061.
Galliez RM, Bomfim L, Mariani D, Leitão IC, Castiñeiras ACP, Gonçalves CCA, et al. Evaluation of the Panbio COVID-19 antigen rapid diagnostic test in subjects infected with omicron using different specimens. Microbiol Spectr 2022;10(3):e0125022.
Garcia-Cardenas F, Franco A, Cortés R, Bertin J, Valdéz R, Peñaloza F, et al. Analytical performances of the COVISTIX™ and Panbio™ antigen rapid tests for SARS-CoV-2 detection in an unselected population (all comers). medRxiv 2021.
Garcia-Cardenas F, Peñaloza F, Bertin-Montoya J, Valdéz-Vázquez R, Franco A, Cortés R, et al. Analytical performances of the COVISTIX™ antigen rapid test for SARS-CoV-2 detection in an unselected population (all-comers). Pathogens 2022;11(6):628.
García-Fernández S, Pablo-Marcos D, de la Fuente SV, Rodríguez MJR, Gozalo M, Rodríguez-Lozano J, et al. Evaluation of the rapid antigen detection test STANDARD F COVID-19 Ag FIA for diagnosing SARS-CoV-2: experience from an emergency department. Diagn Microbiol Infect Dis 2022;103(2):115683.
García-Fiñana M, Hughes DM, Cheyne CP, Burnside G, Stockbridge M, Fowler TA, et al. Performance of the Innova SARS-CoV-2 antigen rapid lateral flow test in the Liverpool asymptomatic testing pilot: population based cohort study. BMJ 2021;374:n1637.
Goga A, Mayne ES, Woeber K, Takuva S, Nsibande D, Lekalakala M, et al. Point-of-care antibody tests for COVID-19: field-based performance, South Africa [CROI Abstract 824]. In special issue: Abstracts from the 2022 Conference on Retroviruses and Opportunistic Infections. Top Antiv Med 2022;30(1s):137.
Gonzalez-Fiallo S, Mena-Rodriguez I, Castro-Batista P, Doeste-Hernandez VM, Louit-Laborit V. Evaluation of SARS-CoV-2 rapid antigen tests in use on the Isle of Youth. Cuba MEDICC Rev 2022;24(2):15–19.
Gupta A, Khurana S, Das R, Srigyan D, Singh A, Mittal A, et al. Rapid chromatographic immunoassay-based evaluation of COVID-19: a cross-sectional, diagnostic test accuracy study & its implications for COVID-19 management in India. Indian J Med Res 2021;153(1 & 2):126–131.
Harris DT, Badowski M, Jernigan B, Sprissler R, Edwards T, Cohen R, et al. SARS-CoV-2 rapid antigen testing of symptomatic and asymptomatic individuals on the University of Arizona Campus. Biomedicines 2021;9(5):539.
Holzner C, Pabst D, Anastasiou OE, Dittmer U, Manegold RK, Risse J, et al. SARS-CoV-2 rapid antigen test: fast-safe or dangerous? An analysis in the emergency department of an university hospital. J Med Virol 2021;93(9):5323–5327.
Homza M, Zelena H, Janosek J, Tomaskova H, Jezo E, Kloudova A, et al. Five antigen tests for SARS-CoV-2: virus viability matters. Viruses 2021;13(4):684.
Hörber S, Drees C, Ganzenmueller T, Schmauder K, Peter S, Biskup D, et al. Evaluation of a laboratory-based high-throughput SARS-CoV-2 antigen assay. Clin Chem Lab Med 2022;60(9):1478–1485.
Ifko M, Tkalčić Švabek Ž, Friščić I, Kardum Paro MM, Prkačin I, Đerek L, et al. Diagnostic validation of two SARS-CoV-2 immunochromatographic tests in Slovenian and Croatian hospitals. Croat Med J 2021;62(5):513–517.
Igloi Z, Velzing J, van Beek J, van de Vijver D, Aron G, Ensing R, et al. Clinical evaluation of Roche SD Biosensor Rapid Antigen Test for SARS-CoV-2 in Municipal Health Service Testing Site, the Netherlands. Emerg Infect Dis 2021;27(5):1323–1329.
Jakobsen KK, Jensen JS, Todsen T, Tolsaard MG, Kirkby N, Lippert F, et al. Accuracy and cost description of rapid antigen test compared with reverse transcriptase-polymerase chain reaction for SARS-CoV-2 detection. Dan Med J 2021;68(7):A03210217.
Jakobsen KK, Jensen JS, Todsen T, Kirkby N, Lippert F, Vangsted AM, et al. Accuracy of anterior nasal swab rapid antigen tests compared with RT-PCR for massive SARS-CoV-2 screening in low prevalence population. APMIS 2022;130(2):95–100.
Jeewandara C, Guruge D, Pushpakumara PD, Madhusanka D, Jayadas TT, Chaturanga IP, et al. Sensitivity and specificity of two WHO approved SARS-CoV2 antigen assays in detecting patients with SARS-CoV2 infection. BMC Infect Dis 2022;22(1):276.
Jegerlehner S, Suter-Riniker F, Jent P, Bittel P, Nagler M. Diagnostic accuracy of a SARS-CoV-2 rapid antigen test in real-life clinical settings. Int J Infect Dis 2021;109:118–122.
Jegerlehner S, Suter-Riniker F, Jent P, Bittel P, Nagler M. Diagnostic accuracy of SARS-CoV-2 saliva antigen testing in a real-life clinical setting. Int J Infect Dis 2022;119:38–40.
Jirungda S, Khamphrom P, Klaprajun K, Prachakul T, Kraisin J. Clinical performance of the standard F COVID-19 AG FIA for the detection of SARS-COV-2 infection. Clinica Chimica Acta 2022;530:S291.
Kahn M, Schuierer L, Bartenschlager C, Zellmer S, Frey R, Freitag M, et al. Performance of antigen testing for diagnosis of COVID-19: a direct comparison of a lateral flow device to nucleic acid amplification based tests. BMC Infect Dis 2021;21(1):798.
Kessler HH, Prüller F, Hardt M, Stelzl E, Föderl-Höbenreich E, Pailer S, et al. Identification of contagious SARS-CoV-2 infected individuals by Roche’s Rapid Antigen Test. Clin Chem Lab Med 2022;60(5):778–785.
Kim D, Lee J, Bal J, Seo SK, Chong CK, Lee JH, et al. Development and clinical evaluation of an immunochromatography-based rapid antigen test (GenBody™ COVAG025) for COVID-19 diagnosis. Viruses 2021;13(5):796.
King C, Lista-de Weever E, Henry M, Steingrover R, Fleming C, Panneflek R, et al. Validation of the Panbio™ COVID-19 Antigen Rapid Test (Abbott) to screen for SARS-CoV-2 infection in Sint Maarten: a diagnostic accuracy study. medRxiv 2021.
Kiyasu Y, Takeuchi Y, Akashi Y, Kato D, Kuwahara M, Muramatsu S, et al. Prospective analytical performance evaluation of the QuickNavi™-COVID19 Ag for asymptomatic individuals. J Infect Chemother 2021;27(10):1489–1492.
Klajmon A, Olechowska-Jarząb A, Salamon D, Sroka-Oleksiak A, Brzychczy-Włoch M, Gosiewski T. Comparison of antigen tests and qPCR in rapid diagnostics of infections caused by SARS-CoV-2 virus. Viruses 2021;14(1):17.
Klein JAF, Krüger LJ, Tobian F, Gaeddert M, Lainati F, Schnitzler P, et al. Head-to-head performance comparison of self-collected nasal versus professional-collected nasopharyngeal swab for a WHO-listed SARS-CoV-2 antigen-detecting rapid diagnostic test. Med Microbiol Immunol 2021;210(4):181–186.
Kohmer N, Toptan T, Pallas C, Karaca O, Pfeiffer A, Westhaus S, et al. Article the comparative clinical performance of four SARS-CoV-2 rapid antigen tests and their correlation to infectivity in vitro. J Clin Med 2021;10(2):1–11.
Korenkov M, Poopalasingam N, Madler M, Vanshylla K, Eggeling R, Wirtz M, et al. Evaluation of a rapid antigen test to detect SARS-CoV-2 infection and identify potentially infectious individuals. J Clin Microbiol 2021;59(9):e0089621.
Korenkov M, Poopalasingam N, Madler M, Vanshylla K, Eggeling R, Wirtz M, et al. Assessment of SARS-CoV-2 infectivity by a rapid antigen detection test. medRxiv 2021.
Krüger LJ, Klein JAF, Tobian F, Gaeddert M, Lainati F, Klemm S, et al. Evaluation of accuracy, exclusivity, limit-of-detection and ease-of-use of LumiraDx™: an antigen-detecting point-of-care device for SARS-CoV-2. Infection 2021. [epub ahead of print].
Krüger LJ, Tanuri A, Lindner AK, Gaeddert M, Köppel L, Tobian F, et al. Accuracy and ease-of-use of seven point-of-care SARS-CoV-2 antigen-detecting tests: a multi-centre clinical evaluation. EBioMedicine 2021. [epub ahead of print].
Krüger LJ, Lindner AK, Gaeddert M, Tobian F, Klein J, Steinke S, et al. A multicenter clinical diagnostic accuracy study of SureStatus, an affordable, WHO emergency use-listed, rapid, point-of-care antigen-detecting diagnostic test for SARS-CoV-2. Microbiol Spectr 2022;10(5):e01229–22.
Krüger LJ, Gaeddert M, Tobian F, Lainati F, Gottschalk C, Klein JAF, et al. The Abbott PanBio WHO emergency use listed, rapid, antigen-detecting point-of-care diagnostic test for SARS-CoV-2-Evaluation of the accuracy and ease-of-use. PLoS One 2021;16(5):e0247918.
Kurihara Y, Kiyasu Y, Akashi Y, Takeuchi Y, Narahara K, Mori S, et al. The evaluation of a novel digital immunochromatographic assay with silver amplification to detect SARS-CoV-2. J Infect Chemother 2021;27(10):1493–1497.
Kweon OJ, Lee JH, Choi YS, Kim BS, Lim YK, Lee MK, et al. Positivity of rapid antigen testing for SARS-CoV-2 with serial followed-up nasopharyngeal swabs in hospitalized patients due to COVID-19. J Korean Med Sci 2022;37(21):e168.
Kyritsi M, Vontas A, Voulgaridi I, Matziri A, Komnos A, Babalis D, et al. Rapid test ag 2019-nCoV (PROGNOSIS, BIOTECH, Larissa, Greece); performance evaluation in hospital setting with real time RT-PCR. Int J Environ Res Public Health 2021;18(17):9151.
Landaverde L, Turcinovic J, Doucette-Stamm L, Gonzales K, Platt J, Connor JH, et al. Comparison of BinaxNOW TM and SARS-CoV-2 qRT-PCR detection of the omicron variant from matched anterior nares swabs 2022;10(6):e0130722.
Layer E, Hoehl S, Widera M, Bojkova D, Westphal T, Gottschalk R, et al. SARS-CoV-2 screening strategies for returning international travellers: evaluation of a rapid antigen test approach. Int J Infect Dis 2022;118:126–131.
LeGoff J, Kernéis S, Elie C, Mercier-Delarue S, Gastli N, Choupeaux L, et al. Evaluation of a saliva molecular point of care for the detection of SARS-CoV-2 in ambulatory care. Sci Rep 2021;11(1):21126.
Leixner G, Voill-Glaninger A, Bonner E, Kreil A, Zadnikar R, Viveiros A. Evaluation of the AMP SARS-CoV-2 rapid antigen test in a hospital setting. Int J Infect Dis 2021;108:353–356.
Linares M, Pérez-Tanoira R, Carrero A, Romanyk J, Pérez-García F, Gómez-Herruz P, et al. Panbio antigen rapid test is reliable to diagnose SARS-CoV-2 infection in the first 7 days after the onset of symptoms. J Clin Virol 2020;133:104659.
Lindner AK, Nikolai O, Kausch F, Wintel M, Hommes F, Gertler M, et al. Head-to-head comparison of SARS-CoV-2 antigen-detecting rapid test with self-collected nasal swab versus professional-collected nasopharyngeal swab. Eur Respir J 2021;57(4):2003961.
Lindner AK, Nikolai O, Rohardt C, Burock S, Hülso C, Bölke A, et al. Head-to-head comparison of SARS-CoV-2 antigen-detecting rapid test with professional-collected nasal versus nasopharyngeal swab. Eur Respir J 2021;57(5):2004430.
Lindner AK, Nikolai O, Rohardt C, Kausch F, Wintel M, Gertler M, et al. Diagnostic accuracy and feasibility of patient self-testing with a SARS-CoV-2 antigen-detecting rapid test. J Clin Virol 2021;141:104874.
Mandal DK, Bhattarai BR, Pokhrel S, Chhusyabaga M, Bhandari P, Bhatt MP, et al. Diagnostic performance of SARS-CoV-2 rapid antigen test in relation to RT-PCR CqValue. Adv Virol 2022;2022:9245248.
Mane A, Jain S, Jain A, Pereira M, Sirsat A, Pathak G, et al. Diagnostic performance of oral swab specimen for SARS-CoV-2 detection with rapid point-of-care lateral flow antigen test. Sci Rep 2022;12(1):7355.
Maniscalco M, Ambrosino P, Ciullo A, Fuschillo S, Valente V, Gaudiosi C, et al. A rapid antigen detection test to diagnose SARS-CoV-2 infection using exhaled breath condensate by a modified Inflammacheck® device. Sensors 2021;21(17):5710.
Masiá M, Fernández-González M, Sánchez M, Carvajal M, García JA, Gonzalo-Jiménez N, et al. Nasopharyngeal Panbio COVID-19 Antigen performed at point-of-care has a high sensitivity in symptomatic and asymptomatic patients with higher risk for transmission and older age. Open Forum Infect Dis 2021;8(3):ofab059.
Mizrahi A, Nguyen Van JC, El Helali N, Lourtet-Hascoet J, Jabnoune I, Pacreau ML, et al. The Coris BioConcept COVID 19 Ag Respi-Strip, a field experience feedback. J Virol Methods 2022;300:114366.
Møller IJB, Utke AR, Rysgaard UK, Østergaard LJ, Jespersen S. Diagnostic performance, user acceptability, and safety of unsupervised SARS-CoV-2 rapid antigen-detecting tests performed at home. Int J Infect Dis 2022;116:358–364.
Nagura-Ikeda M, Imai K, Tabata S, Miyoshi K, Murahara N, Mizuno T, et al. clinical evaluation of self-collected saliva by quantitative reverse transcription-PCR (RT-qPCR), direct RT-qPCR, reverse transcription-loop-mediated isothermal amplification, and a rapid antigen test to diagnose COVID-19. J Clin Microbiol 2020;58(9).
Nikolai O, Rohardt C, Tobian F, Junge A, Corman VM, Jones TC, et al. Anterior nasal versus nasal mid-turbinate sampling for a SARS-CoV-2 antigen-detecting rapid test: does localisation or professional collection matter? Infect Dis 2021;53(12):947–952.
Nóra M, Déri D, Veres DS, Kis Z, Barcsay E, Pályi B. Evaluating the field performance of multiple SARS-Cov-2 antigen rapid tests using nasopharyngeal swab samples. PLoS One 2022;17(2):e0262399.
Okoye GA, Kamara HI, Strobeck M, Mellman TA, Kwagyan J, Sullivan A, et al. Diagnostic accuracy of a rapid diagnostic test for the early detection of COVID-19. J Clin Virol 2022;147:105023.
Onsongo SN, Otieno K, van Duijn S, Adams E, Omollo M, Odero IA, et al. Performance of a rapid antigen test for SARS-CoV-2 in Kenya. Diagn Microbiol Infect Dis 2022;102(2):115591.
Osmanodja B, Budde K, Zickler D, Naik MG, Hofmann J, Gertler M, et al. Accuracy of a novel sars-cov-2 antigen-detecting rapid diagnostic test from standardized self-collected anterior nasal swabs. J Clin Med 2021;10(10):2099.
Paap KC, van Loon AM, Koene FM, van Buul LW, Jurriaans S, Smalbrugge M, et al. Clinical evaluation of single-swab sampling for rapid COVID-19 detection in outbreak settings in Dutch nursing homes. Eur Geriatr Med 2022;13(3):711–718.
Pandey AK, Mohanty A, Hada V, Rath RS, Kumar S, Kishore S, et al. Comparison of the rapid antigen testing method with RT-qPCR for the diagnosis of COVID-19. Cureus 2021;13(8):e17405.
Park JY, Lee JH, Cha BK, Kim B-S, Lee H-J, Kim GH, et al. Analysis of the efficacy of universal screening of coronavirus disease with antigen-detecting rapid diagnostic tests at point-or-care settings and sharing the experience of admission protocol-a pilot study 2022;12(2):319.
Peacock WF, Soto-Ruiz KM, House SL, Cannon CM, Headden G, Tiffany B, et al. Utility of COVID-19 antigen testing in the emergency department. J Am Coll Emerg Physicians Open 2022;3(1):e12605.
Peña M, Ampuero M, Garcés C, Gaggero A, García P, Velasquez MS, et al. Performance of SARS-CoV-2 rapid antigen test compared with real-time RT-PCR in asymptomatic individuals. Int J Infect Dis 2021;107:201–204.
Peña-Rodríguez M, Viera-Segura O, García-Chagollán M, Zepeda-Nuño JS, Muñoz-Valle JF, Mora-Mora J, et al. Performance evaluation of a lateral flow assay for nasopharyngeal antigen detection for SARS-CoV-2 diagnosis. J Clin Lab Anal 2021;35(5):e23745.
Peronace C, Tallerico R, Colosimo M, Sacco V, Talarico R, De Fazio M, et al. Validation of GeneFinder COVID-19 Ag Plus Rapid Test and its potential utility to slowing infection waves: a single-center laboratory evaluation study. Diagnostics 2022;12(5):1126.
Pilarowski G, Lebel P, Sunshine S, Liu J, Crawford E, Marquez C, et al. Performance characteristics of a rapid severe acute respiratory syndrome coronavirus 2 antigen detection assay at a public plaza testing site in San Francisco. J Infect Dis 2021;223(7):1139–1144.
Pollock NR, Jacobs JR, Tran K, Cranston AE, Smith S, O’Kane CY, et al. Performance and implementation evaluation of the Abbott BinaxNOW Rapid Antigen Test in a high-throughput drive-through community testing site in Massachusetts. J Clin Microbiol 2021;59(5):e00083–21.
Poopalasingam N, Korenkov M, Ashurov A, Strobel J, Fish I, Hellmich M, et al. Determining the reliability of rapid SARS-CoV-2 antigen detection in fully vaccinated individuals. J Clin Virol 2022;148:105119.
Prost M. Evaluation of a rapid in vitro diagnostic test device for detection of SARS-CoV-2 antigen in nasal swabs. Health Sci J 2021;15(11):1–3.
Rahman MM, Hoque AF, Karim Y, Kawser Z, Siddik AB, Sumiya MK, et al. Clinical evaluation of SARS-CoV-2 antigen-based rapid diagnostic test kit for detection of COVID-19 cases in Bangladesh. Heliyon 2021;7(11):e08455.
Rana N, Thakur P, Saxena S, Manchanda V, Arora R. Evaluation of the currently used antigen-based rapid diagnostic test for the detection of SARS CoV-2 virus in respiratory specimens. Indian J Med Microbiol 2021;39:S68.
Rastawicki W, Gierczyński R, Juszczyk G, Mitura K, Henry BM. Evaluation of PCL rapid point of care antigen test for detection of SARS-CoV-2 in nasopharyngeal swabs. J Med Virol 2021;93(4):1920–1922.
Soleimani R, Deckers C, Huang TD, Bogaerts P, Evrard S, Wallemme I, et al. Rapid COVID-19 antigenic tests: usefulness of a modified method for diagnosis. J Med Virol 2021;93(9):5655–5659.
Rohde J, Himmel W, Hofinger C, Lâm TT, Schrader H, Wallstabe J, et al. Diagnostic accuracy and feasibility of a rapid SARS-CoV-2 antigen test in general practice - a prospective multicenter validation and implementation study. BMC Prim Care 2022;23(1):149.
Salcedo N, Sena BF, Qu X, Herrera BB. Comparative evaluation of rapid isothermal amplification and antigen assays for screening testing of SARS-CoV-2. Viruses 2022;14(3):468.
Salvagno GL, Gianfilippi G, Bragantini D, Henry BM, Lippi G. Clinical assessment of the Roche SARS-CoV-2 rapid antigen test. Diagnosis 2021;8(3):322–326.
Salvagno GL, Gianfilippi G, Pighi L, De Nitto S, Henry BM, Lippi G. Real-world assessment of Fluorecare SARS-CoV-2 Spike Protein Test Kit. Adv Lab Med 2021;2(3):409–412.
Savage HR, Finch L, Body R, Watkins RL, Hayward G, Cook E, et al. A prospective diagnostic evaluation of accuracy of self-taken and healthcare worker-taken swabs for rapid COVID-19 testing. PLoS One 2022;17(6):e0270715.
Schildgen V, Demuth S, Lüsebrink J, Schildgen O. Limits and opportunities of sars-cov-2 antigen rapid tests: an experienced-based perspective. Pathogens 2021;10(1):1–7.
Selvabai RAP, Koshy LV, Shanmugam P. Diagnostic efficacy of COVID-19 rapid antigen detection card in diagnosis of SARS-CoV-2. J Lab Physicians 2022;14(03):324–328.
Shaw JLV, Deslandes V, Smith J, Desjardins M. Evaluation of the Abbott PanbioTM COVID-19 Ag rapid antigen test for the detection of SARS-CoV-2 in asymptomatic Canadians. Diagn Microbiol Infect Dis 2021;101(4):115514.
Siddiqui ZK, Chaudhary M, Robinson ML, McCall AB, Peralta R, Esteve R, et al. Implementation and accuracy of BinaxNOW Rapid Antigen COVID-19 test in asymptomatic and symptomatic populations in a high-volume self-referred testing site. Microbiol Spectr 2021;9(3):e0100821.
Sitoe N, Sambo J, Nguenha N, Chilaule J, Chelene I, Loquiha O, et al. Performance evaluation of the STANDARD™ Q COVID-19 and Panbio™ COVID-19 antigen tests in detecting SARS-CoV-2 during high transmission period in Mozambique. Diagnostics 2022;12(2):475.
Skvarč M. Clinical validation of two immunochromatographic SARS-CoV-2 antigen tests in near hospital facilities. J Infect Dev Ctries 2022;16(3):418–421.
Smith RD, Johnson JK, Clay C, Girio-Herrera L, Stevens D, Abraham M, et al. Clinical evaluation of Sofia Rapid Antigen Assay for detection of severe acute respiratory syndrome coronavirus 2 among emergency department to hospital admissions. Infect Control Hosp Epidemiol 2021. [epub ahead of print].
Stohr JJJM, Zwart VF, Goderski G, Meijer A, Nagel-Imming CRS, Kluytmans-van den Bergh MFQ, et al. Self-testing for the detection of SARS-CoV-2 infection with rapid antigen tests for people with suspected COVID-19 in the community. Clin Microbiol Infect 2022;28(5):695–700.
Surasi K, Cummings KJ, Hanson C, Kate Morris M, Salas M, Seftel D, et al. Eff ectiveness of abbott binaxnow rapid antigen test for detection of sars-cov-2 infections in outbreak among horse racetrack workers, california, usa. Emerg Infect Dis 2021;27(11):2761–2767.
Suzuki H, Akashi Y, Kato D, Takeuchi Y, Kiyasu Y, Terada N, et al. Analytical performance of rapid antigen tests for the detection of SARS-CoV-2 during widespread circulation of the omicron variant. medRxiv 2022.
Suzuki H, Akashi Y, Ueda A, Kiyasu Y, Takeuchi Y, Maehara Y, et al. Diagnostic performance of a novel digital immunoassay (RapidTesta SARS-CoV-2): a prospective observational study with nasopharyngeal samples. J Infect Chemother 2022;28(1):78–81.
Terpos E, Ntanasis-Stathopoulos I, Skvarč M. Clinical application of a new SARS-CoV-2 antigen detection kit (Colloidal Gold) in the detection of COVID-19. Diagnostics 2021;11(6):995.
Thakur P, Saxena S, Manchanda V, Rana N, Goel R, Arora R. Utility of antigen-based rapid diagnostic test for detection of SARS-CoV-2 virus in routine hospital settings. Lab Med 2021;52(6):e154–e158.
Thell R, Kallab V, Weinhappel W, Mueckstein W, Heschl L, Heschl M, et al. Evaluation of a novel, rapid antigen detection test for the diagnosis of SARS-CoV-2. PLoS One 2021;16(11):e0259527.
Thirion-Romero I, Guerrero-Zúñiga DS, Arias-Mendoza DA, Cornejo-Juárez DDP, Meza-Meneses DP, Torres-Erazo DDS, et al. Evaluation of Panbio rapid antigen test for SARS-CoV-2 in symptomatic patients and their contacts: a multicenter study. Int J Infect Dis 2021;113:218–224.
Tonelotto V, Davini A, Cardarelli L, Calderone M, Marin P. Efficacy of Fluorecare SARS-CoV-2 Spike Protein Test Kit for SARS-CoV-2 detection in nasopharyngeal samples of 121 individuals working in a manufacturing company. PLoS One 2022;17(1):e0262174.
Toptan T, Eckermann L, Pfeiffer AE, Hoehl S, Ciesek S, Drosten C, et al. Evaluation of a SARS-CoV-2 rapid antigen test: potential to help reduce community spread? J Clin Virol 2021;135:104713.
Trobajo-Sanmartín C, Navascués A, Miqueleiz A, Ezpeleta C. Evaluation of the rapid antigen test CerTest SARS-CoV-2 as an alternative COVID-19 diagnosis technique. Infect Dis 2021;53(9):730–732.
Turcato G, Zaboli A, Pfeifer N, Ciccariello L, Sibilio S, Tezza G, et al. Clinical application of a rapid antigen test for the detection of SARS-CoV-2 infection in symptomatic and asymptomatic patients evaluated in the emergency department: a preliminary report. J Infect 2021;82(3):e14–e16.
Turcato G, Zaboli A, Pfeifer N, Sibilio S, Tezza G, Bonora A, et al. Rapid antigen test to identify COVID-19 infected patients with and without symptoms admitted to the emergency department. Am J Emerg Med 2022;51:92–97.
Van der Moeren N, Zwart VF, Lodder EB, Van den Bijllaardt W, Van Esch H, Stohr J, et al. Evaluation of the test accuracy of a SARS-CoV-2 rapid antigen test in symptomatic community dwelling individuals in the Netherlands. PLoS One 2021;16(5):e0250886.
Van Honacker E, Van Vaerenbergh K, Boel A, De Beenhouwer H, Leroux-Roels I, Cattoir L. Comparison of five SARS-COV-2 rapid antigen tests in a hospital setting and performance of one antigen assay in routine practice: a useful tool to guide isolation precautions? J Hosp Infect 2021;114:144–152.
von Ahnen T, von Ahnen M, Wirth U, Schardey HM, Herdtle S. Evaluation of a rapid-antigen test for COVID-19 in an asymptomatic collective: a prospective study. Wien Med Wochenschr 2022;172(3-4):70–73.
Wertenauer C, Brenner Michael G, Dressel A, Pfeifer C, Hauser U, Wieland E, et al. Diagnostic performance of rapid antigen testing for SARS-CoV-2: the COVid-19 AntiGen (COVAG) study. Front Med 2022;9:774550.
World Health Organization. Use of SARS-CoV-2 antigen-detection rapid diagnostic tests for COVID-19 self-testing. Emergencies Preparedness (WPE, Guidelines Review Committee, WHO Headquarters (HQ). World Health Organization; 2022.
Abbott. PanBio COVID-19 Ag Rapid Test device product page [internet]. Abbott; 2023 [cited 2023 Nov 8]. Available from: https://www.globalpointofcare.abbott/en/product-details/panbio-covid-19-ag-antigen-test.html.
Abbott. BinaxNOW COVID-19 Ag Card product page [internet]. Abbott; 2023 [cited 2023 Nov 8]. Available from: https://www.globalpointofcare.abbott/en/product-details/navica-binaxnow-covid-19-us.html.
Roche Diagnostics. SARS-CoV-2 Rapid Antigen Test product page [internet]. Roche Diagnostics; 2023 [cited 2023 Nov 8]. Available from: https://diagnostics.roche.com/global/en/products/params/sars-cov-2-rapid-antigen-test.html.
SD Biosensor. Standard Q COVID-19 Ag product page [internet]. SD Biosensor; 2023 [cited 2023 Jul 2]. Available from: https://www.sdbiosensor.com/product/product_view?product_no=241.
Würstle S, Spinner CD, Voit F, Hoffmann D, Hering S, Weidlich S, et al. Self-sampling versus health care professional-guided swab collection for SARS-CoV-2 testing. Infection 2021;49(5):927–934.
Therchilsen JH, von Buchwald C, Koch A, Dam Nielsen S, Rasmussen DB, Thudium RF, et al. Self-collected versus healthcare worker-collected swabs in the diagnosis of severe acute respiratory syndrome coronavirus 2. Diagnostics 2020;10(9):678.
Cocherie T, Bastide M, Sakhi S, Zafilaza K, Flandre P, Leducq V, et al. decreased sensitivity of rapid antigen test is associated with a lower viral load of omicron than delta SARS-CoV-2 variant. Microbiol Spectr 2022;10(5):e01922–e01922.
Sakai-Tagawa Y, Yamayoshi S, Halfmann PJ, Wilson N, Bobholz M, Vuyk WC, et al. Sensitivity of rapid antigen tests for omicron subvariants of SARS-CoV-2. J Med Virol 2023;95(5):e28788.
Parvu V, Gary DS, Mann J, Lin YC, Mills D, Cooper L, et al. Factors that influence the reported sensitivity of rapid antigen testing for SARS-CoV-2. Front Microbiol 2021;12:714242.
Brümmer LE, Katzenschlager S, McGrath S, Schmitz S, Gaeddert M, Erdmann C, et al. Accuracy of rapid point-of-care antigen-based diagnostics for SARS-CoV-2: An updated systematic review and meta-analysis with meta-regression analyzing influencing factors. PLoS Med 2022;19(5):e1004011.
Glenet M, Lebreil AL, Heng L, N’Guyen Y, Meyer I, Andreoletti L. Asymptomatic COVID-19 adult outpatients identified as significant viable SARS-CoV-2 shedders. Sci Rep 2021;11(1):20615.
Bustin SA, Mueller R. Real-time reverse transcription PCR (qRT-PCR) and its potential use in clinical diagnosis. Clin Sci 2005;109(4):365–379.
Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig L, et al. STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies. BMJ 2015;351:h5527.
Soni A, Herbert C, Lin H, Yan Y, Pretz C, Stamegna P, et al. Performance of rapid antigen tests to detect symptomatic and asymptomatic SARS-CoV-2 infection: a prospective cohort study. Ann Intern Med 2023;176(7):975–982.